Detalhe da pesquisa
1.
Superior Efficacy of a Bedaquiline, Delamanid, and Linezolid Combination Regimen in a Mouse Tuberculosis Model.
J Infect Dis
; 224(6): 1039-1047, 2021 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502537
2.
Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment.
Pharmaceuticals (Basel)
; 16(11)2023 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38004440
3.
A modeling-based proposal for safe and efficacious reintroduction of bedaquiline after dose interruption: A population pharmacokinetics study.
CPT Pharmacometrics Syst Pharmacol
; 11(5): 628-639, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35102712
4.
Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis.
Pharmaceutics
; 14(4)2022 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35456587
5.
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin.
Pharmaceutics
; 14(8)2022 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35893785
6.
Medical Device Apps: An Introduction to Regulatory Affairs for Developers.
JMIR Mhealth Uhealth
; 8(6): e17567, 2020 06 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589154
7.
Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing-Using Rifampicin as an Example.
Front Pharmacol
; 11: 794, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32536870
8.
Mobile Health Apps for Improvement of Tuberculosis Treatment: Descriptive Review.
JMIR Mhealth Uhealth
; 8(4): e17246, 2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32314977